Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2018 08:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY

DANVERS, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
November 01, 2018 20:21 ET | Source: ABIOMED, Inc.

アビオメッド、2019年度第2四半期の収入を発表、収入は前年を37%上回る1億8,200万ドル (約205億円)

マサチューセッツ州ダンバース発, Nov. 02, 2018 (GLOBE NEWSWIRE) -- 画期的な心臓回復およびサポート技術のリーディングプロバイダであるアビオメッド (Abiomed, Inc.、 NASDAQ:ABMD) は本日、2019年度第2四半期に1億8,180万ドル (約205億円) の収入を計上し、2018年度同期の1億3,280万ドル (約150億円)...
November 01, 2018 20:21 ET | Source: ABIOMED, Inc.

Abiomed kündigt Rekordumsatz von 182 Millionen USD für das zweite Quartal des Geschäftsjahres 2019 an – eine Steigerung von 37 % gegenüber dem Vorjahr

DANVERS, Massachusetts, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), ein führender Anbieter bahnbrechender Technologien zur Herzunterstützung und Wiederherstellung der...
November 01, 2018 20:21 ET | Source: ABIOMED, Inc.

Abiomed annonce un chiffre d'affaires record de 182 millions $ pour le deuxième trimestre 2019, soit une hausse de 37 % par rapport au trimestre équivalent de l'exercice précédent

DANVERS, Massachusetts, 02 nov. 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), un fournisseur majeur de technologies innovantes de récupération et d'assistance cardiaque, a annoncé...
November 01, 2018 07:00 ET | Source: ABIOMED, Inc.

Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million, up 37% Over Prior Year

DANVERS, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2019...
October 11, 2018 08:00 ET | Source: ABIOMED, Inc.

Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification

DANVERS, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, November 1, 2018, the Company will release financial results for the second quarter of...
September 24, 2018 08:00 ET | Source: ABIOMED, Inc.

Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival

SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- A new analysis of data from Abiomed's (NASDAQ:ABMD) Impella® Quality (IQ) Database shows a relative increase of 24% in mean survival in acute myocardial...
September 19, 2018 12:53 ET | Source: ABIOMED, Inc.

Abiomed to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018

DANVERS, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), the leader in heart recovery, announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT)...
July 26, 2018 18:56 ET | Source: ABIOMED, Inc.

アビオメッド、2019年度第1四半期の収入を発表、収入は前年度比36%増の1億8,000万ドル

マサチューセッツ州ダンバース発, July 27, 2018 (GLOBE NEWSWIRE) -- 画期的な心臓回復およびサポート技術のリーディングプロバイダーであるアビオメッド (ABIOMED, Inc.、NASDAQ:ABMD) は本日、2019年度第1四半期に1億8,000万ドル (約200億円) の収入を計上し、2018年度同期の1億3,250万ドル (約146億9,000万円)...
July 26, 2018 07:30 ET | Source: ABIOMED, Inc.

Abiomed Announces Approval in India for the Impella 2.5®, Impella CP® and Impella 5.0® Heart Pumps and First Indian Patient Treated

DANVERS, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, announced the Impella 2.5®, Impella CP®...

Next Page keyboard_arrow_right